GlaxoSmithKline, Britain’s biggest pharmaceutical company, has become the world’s first drug major to commit to publishing clinical trial data in a move that campaigners hope will increase the likelihood of medical breakthroughs and protect patients from ill-advised prescriptions.
…The company’s commitment to data transparency follows a high-profile campaign led by Ben Goldacre, a doctor and Guardian columnist, who helped expose drug companies’ manipulation of clinical trial data.
Don’t forget that Sense About Science is fundraising to help the cause further: Sense About Science have agreed to take this on as a campaign, after their excellent work on libel reform. Everything donated will go to support the AllTrials campaign. We will run a public campaign, build an informative website, lobby politicians and stakeholders, brief journalists and make it news.